Jana Čmejlová

Dr. Jana Čmejlová

Laboratory Complement, Research and Breeding Institute of Pomology Holovousy, Jičín, Královéhradecký Kraj, Czech Republic
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2008 in Proteomics
Verified
Journal Article
Open access
PDF file
JPJiří Petrák
Jiří Petrák
RIRobert Ivanek
Robert Ivanek
OTOndrej Toman
Ondrej Toman
RCRadek Cmejla
Radek Cmejla
Jana ČmejlováJana Čmejlová
Jana Čmejlová
CVChristopher D. Vulpe
Christopher D. Vulpe
After reading many 2‐DE‐based articles featuring lists of the differentially expressed proteins, one starts experiencing a disturbing déjà vu. The same proteins seem to predominate regardless of the experiment, tissue or species. To quantify the occurrence of individual differentially expressed proteins in 2‐DE experiment reports, we compiled the identities of differentially expressed proteins identified in human, mouse, and rat tissues published in three recent volumes of Proteomics and calculated the appearance of the most predominant proteins in the dataset. The most frequently identified protein is a highly abundant glycolytic enzyme enolase 1, differentially expressed in nearly every third experiment on both human and rodent tissues. Heat‐shock protein 27 (HSP27) and heat‐shock protein 60 (HSP60) were differentially expressed in about 30 percent of human and rodent samples, respectively. Considering protein families as units, keratins and peroxiredoxins are the most frequently identified molecules, with at least one member of the group being differentially expressed in about 40 percent of all experiments. We suggest that the frequent identification of these proteins must be considered in the interpretation of any 2‐DE studies. We consider if these commonly observed changes represent common cellular stress responses or are a reflection of the technical limitations of 2‐DE.

23 July 2007 in Human Mutation
Verified
Journal Article
Closed access
PDF file
RCRadek Cmejla
Radek Cmejla
Jana ČmejlováJana Čmejlová
Jana Čmejlová
HHHelena Handrkova
Helena Handrkova
JPJiří Petrák
Jiří Petrák
DPDagmar Pospisilova
Dagmar Pospisilova
Diamond‐Blackfan anemia (DBA) is a congenital erythroid aplasia characterized as a normochromic macrocytic anemia with a selective deficiency in red blood cell precursors in otherwise normocellular bone marrow. In 40% of DBA patients, various physical anomalies are also present. Currently two genes are associated with the DBA phenotype—the ribosomal protein (RP) S19 mutated in 25% of DBA patients and RPS24 mutated in ∼1.4% of DBA patients. Here we report the identification of a mutation in yet another ribosomal protein, RPS17. The mutation affects the translation initiation start codon, changing T to G (c.2T>G), thus eliminating the natural start of RPS17 protein biosynthesis. RNA analysis revealed that the mutated allele was expressed, and the next downstream start codon located at position +158 should give rise to a short peptide of only four amino acids (Met‐Ser‐Arg‐Ile). The mutation arose de novo, since all healthy family members carry the wild‐type alleles. The identification of a mutation in the third RP of the small ribosomal subunit in DBA patients further supports the theory that impaired translation may be the main cause of DBA pathogenesis. Hum Mutat 28(12),1178–1182, 2007.

24 February 2009 in Human Mutation
Verified
Journal Article
Open access
PDF file
RCRadek Cmejla
Radek Cmejla
Jana ČmejlováJana Čmejlová
Jana Čmejlová
HHHelena Handrkova
Helena Handrkova
JPJiří Petrák
Jiří Petrák
KPKvetoslava Petrtylova
Kvetoslava Petrtylova
DPDagmar Pospisilova
Dagmar Pospisilova
Diamond‐Blackfan anemia (DBA) is a congenital red blood cell aplasia that is usually diagnosed during early infancy. Apart from defects in red blood cell maturation, the disorder is also associated with various physical anomalies in 40% of patients. Mutations in the ribosomal protein (RP) S19 are found in 25% of patients, while mutations in other proteins of the small ribosomal subunit—RPS17 and RPS24—have been found in a fraction of patients. Recently, mutations in RPL5, RPL11, and RPL35a of the large ribosomal subunit have also been reported in several DBA patients. Here, we present the identification of mutations in the RPL5 and RPL11 genes in patients from the Czech DBA Registry. Mutations in RPL5 were identified in eight patients from 6 out of 28 families (21.4%), and mutations in RPL11 in two patients from 2 out of 28 families (7.1%). Interestingly, all 10 patients with either an RPL5 or RPL11 mutation exhibited one or more physical anomalies; specifically, thumb anomalies (flat thenar) were always present, while no such anomaly was observed in seven patients with an RPS19 mutation. Moreover, 9 out of 10 patients with either an RPL5 or RPL11 mutation were born small for gestational age (SGA) compared to 3 out of 7 patients from the RPS19‐mutated group. These observations may suggest that mutations, at least in RPL5, seem to generally have more profound impact on fetal development than mutations in RPS19. Since RPL5 and RPL11, together with RPL23, are also involved in the MDM2‐mediated p53 pathway regulation, we also screened the RPL23 gene for mutations; however, no mutations were identified. Hum Mutat 0, 1–7, 2009.

1 May 2007 in Haematologica
Verified
Journal Article
Closed access
PDF file
DPD. Pospisilova
D. Pospisilova
Jana ČmejlováJana Čmejlová
Jana Čmejlová
JHJ. Hak
J. Hak
Tomáš AdamTomáš Adam
Tomáš Adam
RCR. Cmejla
R. Cmejla

1 March 2006 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
RCRadek Cmejla
Radek Cmejla
JPJiří Petrák
Jiří Petrák
Jana ČmejlováJana Čmejlová
Jana Čmejlová

17 October 2022 in Horticulture Research
Verified
Journal Article
Open access
PDF file
KHKateřina Holušová
Kateřina Holušová
Jana ČmejlováJana Čmejlová
Jana Čmejlová
PSPavol Suran
Pavol Suran
RČRadek Čmejla
Radek Čmejla
JSJiří Sedlák
Jiří Sedlák
JBJan Bartoš
Jan Bartoš
In sweet cherry (Prunus avium L.), quantitative trait loci have been identified for fruit maturity, colour, firmness, and size to develop markers for marker-assisted selection. However, resolution is usually too low in those analyses to directly target candidate genes, and some associations are missed. In contrast, genome-wide association studies are performed on broad collections of accessions, and assemblies of reference sequences from Tieton and Satonishiki cultivars enable identification of single nucleotide polymorphisms after whole-genome sequencing, providing high marker density. Two hundred and thirty-five sweet cherry accessions were sequenced and phenotyped for harvest time and fruit colour, firmness, and size. Genome-wide association studies were used to identify single nucleotide polymorphisms associated with each trait, which were verified in breeding material consisting of 64 additional accessions. A total of 1,767,106 single nucleotide polymorphisms were identified. At that density, significant single nucleotide polymorphisms could be linked to co-inherited haplotype blocks (median size ~10 kb). Thus, markers were tightly associated with respective phenotypes, and individual allelic combinations of particular single nucleotide polymorphisms provided links to distinct phenotypes. In addition, yellow-fruit accessions were sequenced, and a ~90-kb-deletion on chromosome 3 that included five MYB10 transcription factors was associated with the phenotype. Overall, the study confirmed numerous quantitative trait loci from bi-parental populations using high-diversity accession populations, identified novel associations, and genome-wide association studies reduced the size of trait-associated loci from megabases to kilobases and to a few candidate genes per locus. Thus, a framework is provided to develop molecular markers and evaluate and characterize genes underlying important agronomic traits.